Galena Biopharma (SLS)
(Delayed Data from NSDQ)
$1.36 USD
+0.07 (5.04%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.35 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Galena Biopharma, Inc. [SLS]
Reports for Purchase
Showing records 1 - 7 ( 7 total )
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
First Ovarian Cancer Data Point in Right Direction; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
2017 Results; Driving Towards Critical Programs for GPS; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
GPS Positioning for Success Across Multiple Tumor Types; Initiating at Buy, $11 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Galena Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
With Primary Focus on Galinpepimut-S, NeuVax Gets a Nice Boost
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
|